Acceleron Pharma Inc Revenu
Quel est le Revenu de Acceleron Pharma Inc?
Le Revenu de Acceleron Pharma Inc est -$254.85
Quelle est la définition de Revenu?
Le résultat net disponible pour les actionnaires ordinaires correspond au résultat net moins les dividendes privilégiés versés.
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Revenu des entreprises dans Health Care secteur sur NASDAQ par rapport à Acceleron Pharma Inc
Que fait Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Entreprises avec revenu similaire à Acceleron Pharma Inc
- Party City Holdco Inc a Revenu de -$257.19
- Yunfeng a Revenu de -HKD$256.40
- Molecular Data Inc a Revenu de -¥255.83
- Kallam Spinning Mills a Revenu de -₨255.70
- IAMGOLD a Revenu de -$255.20
- HUTCHMED (China) a Revenu de -$255.11
- Acceleron Pharma Inc a Revenu de -$254.85
- ADLER Real Estate AG a Revenu de -€254.84
- Arconic a Revenu de -$254.00
- Arconic a Revenu de -$254.00
- Ind-Swift a Revenu de -₨253.71
- Direct Line Insurance Plc a Revenu de -£253.70
- Rocket Pharmaceuticals Inc a Revenu de -$253.26